Literature DB >> 16789014

Optimized virus disruption improves detection of HIV-1 p24 in particles and uncovers a p24 reactivity in patients with undetectable HIV-1 RNA under long-term HAART.

Jörg Schüpbach1, Zuzana Tomasik, Marlyse Knuchel, Milos Opravil, Huldrych F Günthard, David Nadal, Jürg Böni.   

Abstract

HIV-1 p24 antigen (p24) measurement by signal amplification-boosted ELISA of heat-denatured plasma is being evaluated as an alternative to HIV-1 RNA quantitation in resource-poor settings. Some observations suggested that virion-associated p24 is suboptimally detected using Triton X-100-based virus dissociation buffer (kit buffer). A new reagent (SNCR buffer) containing both denaturing and non-denaturing detergents was therefore developed and evaluated. The SNCR buffer increased the measured p24 concentration about 1.5- to 3-fold in HIV-negative plasma reconstituted with purified HIV-1 particles, while not increasing the background. Among 127 samples of HIV-1-positive patients with moderate to high concentrations of HIV-1 RNA the increase was about threefold across the entire concentration range (P < 0.0001). Specificity before neutralization among prospectively tested clinical samples ruled HIV-negative was 828 of 845 (98.0%) for the SNCR buffer and 464 of 479 (96.9%) for kit buffer. Specificity after confirmatory neutralization of reactive samples or a follow-up test was 100% with either buffer. Surprisingly, the SNCR buffer revealed a p24 reactivity in 115 of 187 samples (61.5%) from adult patients exhibiting undetectable HIV-1 RNA below 5 copies/ml for a duration of 6-30 months under HAART (3.7% with kit buffer). The rate of p24 reactivity in these patients did not decrease with duration of HAART. In conclusion, the SNCR buffer improves the detection of particle-associated HIV-1 p24, thereby increasing the measured p24 concentration in samples with medium to high HIV-1 RNA. It also uncovers the presence of a p24 reactivity, whose identity remains to be determined, in a significant fraction of samples with undetectable HIV-1 RNA under long-term HAART. 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16789014     DOI: 10.1002/jmv.20655

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  15 in total

1.  Characterization of immune responses to capsid protein p24 of human immunodeficiency virus type 1 and implications for detection.

Authors:  Shixing Tang; Jiangqin Zhao; Aifeng Wang; Ragupathy Viswanath; Harri Harma; Richard F Little; Robert Yarchoan; Susan L Stramer; Phillipe N Nyambi; Sherwin Lee; Owen Wood; Eric Y Wong; Xue Wang; Indira K Hewlett
Journal:  Clin Vaccine Immunol       Date:  2010-06-09

2.  Detection of HIV gp120 in plasma during early HIV infection is associated with increased proinflammatory and immunoregulatory cytokines.

Authors:  Jenna Rychert; Daryld Strick; Sue Bazner; James Robinson; Eric Rosenberg
Journal:  AIDS Res Hum Retroviruses       Date:  2010-08-19       Impact factor: 2.205

3.  Performance of an alternative HIV diagnostic algorithm using the ARCHITECT HIV Ag/Ab Combo assay and potential utility of sample-to-cutoff ratio to discriminate primary from established infection.

Authors:  Eric M Ramos; Socorro Harb; Joan Dragavon; Paul Swenson; Joanne D Stekler; Robert W Coombs
Journal:  J Clin Virol       Date:  2013-08-26       Impact factor: 3.168

4.  Potential of a simplified p24 assay for early diagnosis of infant human immunodeficiency virus type 1 infection in Haiti.

Authors:  Erik George; Carole Anne Beauharnais; Emilio Brignoli; Francine Noel; Gyrlande Bois; Patricia De Matteis Rouzier; Martine Altenor; Daniel Lauture; Marlène Hosty; Sapna Mehta; Peter F Wright; Jean W Pape
Journal:  J Clin Microbiol       Date:  2007-08-01       Impact factor: 5.948

5.  Combining Cell and Gene Therapy in an Effort to Eradicate HIV.

Authors:  Thor A Wagner
Journal:  AIDS Patient Care STDS       Date:  2016-12       Impact factor: 5.078

6.  Diagnostic accuracy of ultrasensitive heat-denatured HIV-1 p24 antigen in non-B subtypes in Kampala, Uganda.

Authors:  L A Spacek; F Lutwama; H M Shihab; J Summerton; M R Kamya; A Ronald; O Laeyendecker; T C Quinn; H Mayanja-Kizza
Journal:  Int J STD AIDS       Date:  2011-06       Impact factor: 1.359

7.  Increased Sensitivity of HIV-1 p24 ELISA Using a Photochemical Signal Amplification System.

Authors:  Simon Bystryak; Rasa Santockyte
Journal:  J Acquir Immune Defic Syndr       Date:  2015-10-01       Impact factor: 3.731

8.  Detection of HIV-1 p24 antigen in patients with varying degrees of viremia using an ELISA with a photochemical signal amplification system.

Authors:  Simon Bystryak; Chitrangada Acharya
Journal:  Clin Chim Acta       Date:  2016-03-03       Impact factor: 3.786

9.  Evaluation of the ultrasensitive human immunodeficiency virus type 1 (HIV-1) p24 antigen assay performed on dried blood spots for diagnosis of HIV-1 infection in infants.

Authors:  Janet C Patton; Ashraf H Coovadia; Tammy M Meyers; Gayle G Sherman
Journal:  Clin Vaccine Immunol       Date:  2007-12-05

10.  Retired Nurses Can Improve Retention in Prevention of Mother-to-Child Transmission Programmes.

Authors:  Zahra Persson Theilgaard; Mercy G Chiduo; Leo Flamholc; Jan Gerstoft; Ib C Bygbjerg; Martha Moshi Lemnge; Terese L Katzenstein
Journal:  East Afr Health Res J       Date:  2019-11-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.